ArticleOncoimmunology2021

CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients.

Lourdes Gimeno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.